Institutional Ownership Amylyx Pharmaceuticals, Inc. (AMLX)
This table provides information about the institutional ownership of Amylyx Pharmaceuticals, Inc. (AMLX). We have compiled data on the 142 institutions that hold shares in the stock, with a total of 75.8 Million shares, which have been reported (via 13F filing form) to have a value of $797 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
646,443
shares
|
$6.79 Million
0.03% of portfolio
|
Q2 2025
Added 451.86%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Aug 12, 2025 Q2 2025 |
616,919
shares
|
$6.48 Million
0.0% of portfolio
|
Q2 2025
Added 8.07%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
601,646
shares
|
$6.32 Million
0.02% of portfolio
|
Q2 2023
Reduced 58.04%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
588,411
shares
|
$6.18 Million
0.0% of portfolio
|
Q2 2025
Added 57.81%
|
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
586,883
shares
|
$6.17 Million
0.0% of portfolio
|
Q2 2025
Added 1184.38%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Aug 07, 2025 Q2 2025 |
569,083
shares
|
$5.98 Million
0.01% of portfolio
|
Q2 2025
Added 135.05%
|
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
558,846
shares
|
$5.87 Million
0.01% of portfolio
|
Q2 2025
Reduced 26.67%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
499,764
shares
|
$5.25 Million
0.22% of portfolio
|
Q2 2025
Added 45.61%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
486,893
shares
|
$5.12 Million
0.0% of portfolio
|
Q2 2025
Added 2.63%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
470,000
shares
|
$4.94 Million
0.01% of portfolio
|
Q2 2025
Reduced 27.67%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
451,808
shares
|
$4.75 Million
0.0% of portfolio
|
Q2 2025
Reduced 43.12%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
438,026
shares
|
$4.6 Million
0.0% of portfolio
|
Q2 2025
Reduced 53.54%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
396,200
shares
|
$4.16 Million
0.0% of portfolio
|
Q2 2025
Reduced 23.08%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
373,739
shares
|
$3.93 Million
0.0% of portfolio
|
Q2 2025
Added 202.44%
|
|
|
Ghost Tree Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
325,000
shares
|
$3.42 Million
0.39% of portfolio
|
Q3 2024
New holding
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
313,200
shares
|
$3.29 Million
0.07% of portfolio
|
Q2 2025
Reduced 10.0%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
295,000
shares
|
$3.1 Million
1.83% of portfolio
|
Q3 2023
Added 1080.0%
|
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
288,618
shares
|
$3.03 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.71%
|
|
|
Alpha Wave Global, LP
New York, NY |
Aug 13, 2025 Q2 2025 |
275,842
shares
|
$2.9 Million
0.86% of portfolio
|
Q2 2025
Added 47.26%
|
|
|
J. Goldman & CO LP
New York, NY |
Aug 14, 2025 Q2 2025 |
258,600
shares
|
$2.72 Million
0.04% of portfolio
|
Q2 2025
New holding
|
|
|
Y Intercept (Hong Kong) LTD
|
Aug 01, 2025 Q2 2025 |
240,379
shares
|
$2.53 Million
0.04% of portfolio
|
Q2 2025
New holding
|
|
|
Tfg Asset Management Gp LTD
Grand Cayman, E9 |
Aug 14, 2025 Q2 2025 |
218,750
shares
|
$2.3 Million
0.35% of portfolio
|
Q2 2025
New holding
|
|
|
Aldebaran Capital, LLC
Indianapolis, IN |
Aug 12, 2025 Q2 2025 |
217,827
shares
|
$2.29 Million
1.38% of portfolio
|
Q2 2025
Reduced 15.98%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Aug 13, 2025 Q2 2025 |
203,930
shares
|
$2.14 Million
0.0% of portfolio
|
Q2 2025
Added 0.56%
|
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
186,986
shares
|
$1.97 Million
0.0% of portfolio
|
Q2 2025
Reduced 43.54%
|